Eton Pharmaceuticals, Inc. (ETON): Free Cash Flow
$10.19M
Year ended 2025-12-31
$14.73M
Trailing 12 months to 2026-06-30
+28.7%
3-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.19M | +980.7% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $943.0K | -86.2% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $6.82M | +42.5% | 2026-03-19, From 2023-01-01 |
| 2022-12-31 | $4.78M | n/m | 2025-03-18, From 2022-01-01 |
| 2021-12-31 | -$4.73M | n/m | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | -$22.40M | n/m | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | -$19.12M | n/m | 2022-03-16, From 2019-01-01 |
| 2018-12-31 | -$8.38M | n/a | 2021-03-16, From 2018-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $10.19M | +980.7% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | -$141.44M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$74.50M | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$75.81M | n/m |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | -$263.47M | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$171.21M | n/m |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | -$174.07M | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | -$82.65M | n/m |
| Cytokinetics Inc (CYTK) | 2025-12-31 | -$534.82M | n/m |
Compare ETON, ADCT, ARCT, CTMX side by side · Screen every company in Pharmaceutical Preparations ↗